ProCE Banner Activity

CE / CME

Targeting Weight Loss “First” in Type 2 Diabetes Care With GLP-1 RAs

Clinical Thought

Read an expert’s perspective on how the latest treatment options for type 2 diabetes can prioritize both glycemic control and weight management.

ABIM MOC: maximum of 0.25 Medical Knowledge MOC point

Physician Assistants/Physician Associates: 0.25 AAPA Category 1 CME credit

Nurses: 0.25 Nursing contact hour

Physicians: maximum of 0.25 AMA PRA Category 1 Credit

Released: March 28, 2024

Expiration: March 27, 2025

Share

Faculty

Nicole Ehrhardt

Nicole Ehrhardt, MD

Assistant Professor of Medicine
UW Medicine Diabetes Institute
Seattle, Washington

Provided by

Provided by Clinical Care Options, LLC in partnership with Practicing Clinicians Exchange, LLC and the National AHEC Organization

ProCE Banner

Supporters

This activity is supported by an educational grant from Lilly.

Lilly

Partners

National AHEC Organization

ProCE Banner

Practicing Clinicians Exchange

ProCE Banner

Target Audience

This program is intended for US primary care physicians, nurse practitioners, and physician assistants/physician associates.

Program Learning Goal

The goal of this program is to improve the knowledge, competence, and performance of primary care providers to optimize treatment of patients with T2D and overweight/obesity.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Select T2D treatments that reflect guideline recommendations and individual patient needs

Disclosure

Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Primary Author

Nicole Ehrhardt, MD

Assistant Professor of Medicine
UW Medicine Diabetes Institute
Seattle, Washington

Nicole Ehrhardt, MD: consultant/advisor/speaker: Bayer, Dexcom, Novo Nordisk; researcher: Dexcom, Novo Nordisk.

The planners and content peer reviewers from Clinical Care Options, LLC do not have any relevant financial relationships to disclose, except Amy Butts PA-C, DFAAPA, BC-ADM, CDCES and Lucia M. Novak, MSN, ANP-BC, BC-ADM, as noted below.

Amy Butts, PA-C, DFAAPA, BC-ADM, CDCESconsultant/advisor/speaker: Abbott, Ascencia/Eversense, Bayer, Novo Nordisk, Xeris.

Lucia M. Novak, MSN, ANP-BC, BC-ADMconsultant/advisor/speaker: Abbott Diabetes Care, Ascensia, Boehringer Ingelheim, Boehringer Ingelheim Lilly Alliance, Medtronic, Novo Nordisk, Sanofi.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 0.25 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from March 28, 2024, through March 27, 2025:

  1. Login or Sign Up for an account by clicking at the top of this page.
  2. Read the target audience, learning objectives, and faculty disclosures.
  3. View and study the content in its entirety.
  4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65 and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the confirmation page. Records of all CME/CE activities completed can be found on the "My Certificates" page. There are no costs/fees for this activity.

Format

This program has been made available online.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Accreditation

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Clinical Care Options, LLC (CCO) and the National AHEC Organization. Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 0.25 contact hours.

Physician Associate Continuing Medical Education

LogoDescription automatically generated

Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.25 AAPA Category 1 CME credits. Approval is valid until March 27, 2025. PAs should only claim credit commensurate with the extent of their participation.

American Board of Internal Medicine MOC

A blue and white signDescription automatically generated with low confidence

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

To receive CME credit and/or MOC points, you MUST pass the post-test and complete the evaluation. For ABIM MOC points, your information will be shared with the ABIM through CCO’s Joint Accreditation Program and Activity Reporting System (JAPARS). Please allow 6-8 weeks for your MOC points to appear on your ABIM records.

By sharing your Diplomate Board ID # and DOB, you are giving Clinical Care Options, LLC permission to use this information/data to report your participation to these Boards via the Joint Accreditation Program and Activity Reporting System (JA-PARS).